Baxter Q1 beats: sales $2.63B, adj. EPS $0.55; FY guidance raised to $2.47-$2.55

BAXTER INTERNATIONAL INC

2025-Q1 EPS reported $0.25 revenue$2,625,000,000

First-quarter sales $2.63B, up 5% reported and operational, exceeding guidance.
GAAP diluted EPS from continuing ops $0.13; adjusted diluted EPS $0.55, both above guidance.
Full-year 2025 adjusted EPS guidance raised: lower end increased to $2.47-$2.55 range.
Chair and interim CEO Brent Shafer cites transformation progress and focus on essential medtech.
Management notes global macroeconomic uncertainty but remains confident in trajectory.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.